Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
31
CNSP Quote, Financials, Valuation and Earnings
Last price:
$1.12
Seasonality move
:
-2.42%
Day range:
$1.00 - $1.13
52-week range:
$0.99 - $800.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.54x
Volume:
73.1K
Avg. volume:
302.5K
1-year change:
-99.8%
Market cap:
$3.3M
Revenue:
--
EPS (TTM):
-$70.72
Earnings Data
Next earnings date for CNSP
May 15
2025
Most recent earnings per share
-$2.25
Missed by $2.25
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CNSP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -$2.25 | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$12.50 | -- | -- |
| 08/14/2024 | Q2 | -- | -- | -$336.00 | -- | -- |
| 05/15/2024 | Q1 | -- | -- | -$1,025.00 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$2,163.08 | -- | -- |
| 11/15/2023 | Q3 | -- | -- | -$2,707.00 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$2,593.00 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$5,541.51 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$7,951.78 | -- | -- |
| 11/11/2022 | Q3 | -- | -- | -$6,415.67 | -- | -- |
| 08/12/2022 | Q2 | -- | -- | -$6,690.34 | -- | -- |
| 05/13/2022 | Q1 | -- | -- | -$5,913.28 | -- | -- |
| 03/03/2022 | Q4 | -- | -- | -$8,746.71 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$10,421.72 | -- | -- |
| 08/13/2021 | Q2 | -- | -- | -$10,448.42 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$10,690.54 | -- | -- |
| 03/12/2021 | Q4 | -- | -- | -$9,449.39 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$9,058.85 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$11,295.76 | -- | -- |
| 05/15/2020 | Q1 | -- | -- | -$8,986.90 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$11,540.40 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$3,381.12 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$2,065.58 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1,011.97 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$31,729.73 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$924.42 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$1,231.98 | -- | -- |
CNS Pharmaceuticals Earnings Questions
-
How Much did CNS Pharmaceuticals Generate in Revenue Last Quarter?
CNS Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did CNS Pharmaceuticals Beat Earnings Last Quarter?
CNS Pharmaceuticals announced earnings per share of -$2.25 which represents a miss of analyst forecast a -- per share.
-
Is CNS Pharmaceuticals Profitable?
CNS Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for CNS Pharmaceuticals EPS Next Year?
CNS Pharmaceuticals's earnings are forecast to grow from -$1,943.50 per share to -- per share next year representing an increase of --.
-
When is CNS Pharmaceuticals's Earnings Date?
CNS Pharmaceuticals's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 9.68% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 7.14% over the past day.
Sell
47
FNGO alert for Apr 10
MicroSectors FANG+ Index 2X Leveraged ETN [FNGO] is down 6.85% over the past day.
